lysophosphatidic acid

vascular endothelial growth factor A ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33916643 LPA1 Receptor Promotes Progesterone Receptor Phosphorylation through PKCα in Human Glioblastoma Cells. 2021 Apr 4 1
2 24131310 Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. 2014 Apr 2
3 24879414 Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression. 2014 2
4 23831623 Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells. 2013 Aug 2 10
5 24113377 Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells. 2013 Nov 1 2
6 22911748 Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells. 2012 1
7 21782227 The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). 2011 Oct 9
8 20177148 Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells. 2010 Apr 30 3
9 20197381 Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. 2010 Mar 2
10 19147754 Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. 2009 Jan 15 9
11 19193014 Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. 2009 Sep 4
12 19765808 VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion. 2009 Dec 4
13 19860625 Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression. 2009 Dec 2
14 18171700 Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome. 2008 Mar 1
15 18337445 Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. 2008 Mar 2
16 18396013 Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies. 2008 Jun 12
17 18617617 Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta. 2008 Nov 1
18 18642114 Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells. 2008 Sep 2
19 17919812 Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. 2007 Dec 8 3
20 17085645 Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. 2006 Nov 1 7
21 15919106 LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2). 2005 Jun 5
22 12668280 Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. 2003 Mar 31 1
23 12759391 Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. 2003 May 21 4
24 11353786 Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. 2001 May 16 4
25 10645770 Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. 1999 Dec 2